Literature DB >> 17182346

Anti-infective research and development--problems, challenges, and solutions.

John S Bradley1, Robert Guidos, Steve Baragona, John G Bartlett, Ethan Rubinstein, George G Zhanel, Michael D Tino, David L Pompliano, Frank Tally, Praveen Tipirneni, Glenn S Tillotson, John H Powers, Glenn S Tillotson.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17182346     DOI： 10.1016/S1473-3099(06)70689-2

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  15 in total

Review 1.  Novel approaches to developing new antibiotics for bacterial infections.

Authors:  A R M Coates; Y Hu
Journal:  Br J Pharmacol       Date:  2007-08-20       Impact factor: 8.739

2.  Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models.

Authors:  Rajesh V Dudhani; John D Turnidge; Kingsley Coulthard; Robert W Milne; Craig R Rayner; Jian Li; Roger L Nation
Journal:  Antimicrob Agents Chemother       Date:  2009-12-22       Impact factor: 5.191

3.  Antimicrobial Activity of Selected Polyphenols and Capsaicinoids Identified in Pepper (Capsicum annuum L.) and Their Possible Mode of Interaction.

Authors:  Meriem Mokhtar; Giovanna Ginestra; Fatma Youcefi; Angela Filocamo; Carlo Bisignano; Ali Riazi
Journal:  Curr Microbiol       Date:  2017-07-18       Impact factor: 2.188

4.  In silico and in vivo evaluation of bacteriophage phiEF24C, a candidate for treatment of Enterococcus faecalis infections.

Authors:  Jumpei Uchiyama; Mohammad Rashel; Iyo Takemura; Hiroshi Wakiguchi; Shigenobu Matsuzaki
Journal:  Appl Environ Microbiol       Date:  2008-05-02       Impact factor: 4.792

5.  Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing design.

Authors:  Cornelia B Landersdorfer; Neang S Ly; Hongmei Xu; Brian T Tsuji; Jürgen B Bulitta
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

6.  Characterization of VCC-1, a Novel Ambler Class A Carbapenemase from Vibrio cholerae Isolated from Imported Retail Shrimp Sold in Canada.

Authors:  Chand S Mangat; David Boyd; Nicol Janecko; Sarah-Lynn Martz; Andrea Desruisseau; Michael Carpenter; Richard J Reid-Smith; Michael R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2016-01-11       Impact factor: 5.191

Review 7.  Significance and biological importance of pyrimidine in the microbial world.

Authors:  Vinita Sharma; Nitin Chitranshi; Ajay Kumar Agarwal
Journal:  Int J Med Chem       Date:  2014-03-23

8.  Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial.

Authors:  Jochen W L Cals; Christopher C Butler; Rogier M Hopstaken; Kerenza Hood; Geert-Jan Dinant
Journal:  BMJ       Date:  2009-05-05

9.  New disturbing trend in antimicrobial resistance of gram-negative pathogens.

Authors:  Jung Hun Lee; Seok Hoon Jeong; Sun-Shin Cha; Sang Hee Lee
Journal:  PLoS Pathog       Date:  2009-03-27       Impact factor: 6.823

10.  Liposome-encapsulated ISMN: a novel nitric oxide-based therapeutic agent against Staphylococcus aureus biofilms.

Authors:  Camille Jardeleza; Shasha Rao; Benjamin Thierry; Pratik Gajjar; Sarah Vreugde; Clive A Prestidge; Peter-John Wormald
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.